🇺🇸 FDA
Patent

US 9855291

Anti-kidney associated antigen 1 (KAAG1) antibodies

granted A61KA61K2039/505A61K31/7088

Quick answer

US patent 9855291 (Anti-kidney associated antigen 1 (KAAG1) antibodies) held by ADC THERAPEUTICS SA expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ADC THERAPEUTICS SA
Grant date
Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K31/7088, A61P, A61P35/00